These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle.
    Author: Tajimi M, Ozaki H, Sato K, Karaki H.
    Journal: Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):602-10. PubMed ID: 1667330.
    Abstract:
    1. The effects of a novel cyclic AMP phosphodiesterase inhibitor, E-1020 (1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate), on cytosolic Ca++ level ([Ca++]cyt) and muscle tension were examined in rat aorta using a fluorescent Ca++ indicator, fura-2. 2. The sustained contraction induced by norepinephrine was more strongly inhibited by E-1020 than that induced by high K+. The contraction induced by a higher concentration of the stimulant was less sensitive to E-1020 than that due to a lower concentration. 3. Contractions induced by high K+ and norepinephrine followed the increase in [Ca++]cyt. E-1020 inhibited the increments in [Ca++]cyt and muscle tension. A Ca++ channel blocker, verapamil, inhibited the norepinephrine-stimulated [Ca++]cyt more strongly than the contraction. E-1020 inhibited the verapamil-insensitive portion of the norepinephrine-stimulated [Ca++]cyt and contraction. 4. Norepinephrine transiently increased [Ca++]cyt and muscle tension in Ca(++)-free solution. E-1020 inhibited the transient contraction but not the stimulated [Ca++]cyt. 5. E-1020 increased the cyclic AMP content of the muscle. The effects of E-1020 on cyclic AMP content and contraction were potentiated by an activator of adenylate cyclase, forskolin. 6. These results suggest that E-1020 inhibits the vascular contractility by the decrease in [Ca++]cyt and decrease in Ca++ sensitivity of contractile elements. These effects may be mediated by the increase in cyclic AMP content of the muscle.
    [Abstract] [Full Text] [Related] [New Search]